| QA0 |
Neurodevelopmental disorders related to specific genetic pathogenic variants |
| QA0.0 |
Neurodevelopmental disorders related to pathogenic variants in specific genes |
| QA0.01 |
Neurodevelopmental disorders related to pathogenic variants in certain specific genes |
| QA0.010 |
Neurodevelopmental disorders, related to pathogenic variants in ion channel genes |
| QA0.0102 |
CACNA1A-related neurodevelopmental disorder |
| QA0.0109 |
Neurodevelopmental disorder related to pathogenic variant in other ion channel gene |
| QA0.011 |
Neurodevelopmental disorders, related to pathogenic variants in glutamate receptor genes |
| QA0.012 |
Neurodevelopmental disorders, related to pathogenic variants in other receptor genes |
| QA0.013 |
Neurodevelopmental disorders, related to pathogenic variants in other transporter and solute carrier genes |
| QA0.0131 |
SLC6A1-related disorder |
| QA0.0139 |
Neurodevelopmental disorder, related to pathogenic variant in other transporter or solute carrier gene |
| QA0.014 |
Neurodevelopmental disorders, related to pathogenic variants in synapse related genes |
| QA0.0141 |
Syntaxin-binding protein 1-related disorder |
| QA0.0142 |
DLG4-related synaptopathy |
| QA0.0149 |
Neurodevelopmental disorder, related to pathogenic variant in other synapse related gene |
| QA0.015 |
Neurodevelopmental disorders, related to genes associated with transcription and gene expression |
| QA0.0151 |
FOXG1 syndrome |
| QA0.0159 |
Neurodevelopmental disorder, related to other genes associated with transcription and gene expression |
| QA0.8 |
Other neurodevelopmental disorders related to pathogenic variants in other specific genes |